| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |